613 related articles for article (PubMed ID: 33220252)
1. The Colombian Chemoprevention Trial: 20-Year Follow-Up of a Cohort of Patients With Gastric Precancerous Lesions.
Piazuelo MB; Bravo LE; Mera RM; Camargo MC; Bravo JC; Delgado AG; Washington MK; Rosero A; Garcia LS; Realpe JL; Cifuentes SP; Morgan DR; Peek RM; Correa P; Wilson KT
Gastroenterology; 2021 Mar; 160(4):1106-1117.e3. PubMed ID: 33220252
[TBL] [Abstract][Full Text] [Related]
2. Dynamics of
Mera RM; Bravo LE; Camargo MC; Bravo JC; Delgado AG; Romero-Gallo J; Yepez MC; Realpe JL; Schneider BG; Morgan DR; Peek RM; Correa P; Wilson KT; Piazuelo MB
Gut; 2018 Jul; 67(7):1239-1246. PubMed ID: 28647684
[TBL] [Abstract][Full Text] [Related]
3. Helicobacter pylori associated gastric intestinal metaplasia: Treatment and surveillance.
Liu KS; Wong IO; Leung WK
World J Gastroenterol; 2016 Jan; 22(3):1311-20. PubMed ID: 26811668
[TBL] [Abstract][Full Text] [Related]
4. Predictors for regression and progression of intestinal metaplasia (IM): A large population-based study from low prevalence area of gastric cancer (IM-predictor trial).
Aumpan N; Vilaichone RK; Pornthisarn B; Chonprasertsuk S; Siramolpiwat S; Bhanthumkomol P; Nunanan P; Issariyakulkarn N; Ratana-Amornpin S; Miftahussurur M; Mahachai V; Yamaoka Y
PLoS One; 2021; 16(8):e0255601. PubMed ID: 34379655
[TBL] [Abstract][Full Text] [Related]
5. Long-Term Follow-up of Gastric Precancerous Lesions in a Low GC Incidence Area.
Chapelle N; Péron M; Quénéhervé L; Bourget A; Leroy M; Touchefeu Y; Cauchin E; Coron E; Mosnier JF; Matysiak-Budnik T
Clin Transl Gastroenterol; 2020 Dec; 11(12):e00237. PubMed ID: 33512802
[TBL] [Abstract][Full Text] [Related]
6. Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions.
You WC; Brown LM; Zhang L; Li JY; Jin ML; Chang YS; Ma JL; Pan KF; Liu WD; Hu Y; Crystal-Mansour S; Pee D; Blot WJ; Fraumeni JF; Xu GW; Gail MH
J Natl Cancer Inst; 2006 Jul; 98(14):974-83. PubMed ID: 16849680
[TBL] [Abstract][Full Text] [Related]
7. Factors predicting progression of gastric intestinal metaplasia: results of a randomised trial on Helicobacter pylori eradication.
Leung WK; Lin SR; Ching JY; To KF; Ng EK; Chan FK; Lau JY; Sung JJ
Gut; 2004 Sep; 53(9):1244-9. PubMed ID: 15306578
[TBL] [Abstract][Full Text] [Related]
8. Helicobacter pylori infection and development of gastric cancer in Korea: long-term follow-up.
Kim N; Park RY; Cho SI; Lim SH; Lee KH; Lee W; Kang HM; Lee HS; Jung HC; Song IS
J Clin Gastroenterol; 2008; 42(5):448-54. PubMed ID: 18344895
[TBL] [Abstract][Full Text] [Related]
9. Helicobacter pylori eradication cannot reduce the risk of gastric cancer in patients with intestinal metaplasia and dysplasia: evidence from a meta-analysis.
Chen HN; Wang Z; Li X; Zhou ZG
Gastric Cancer; 2016 Jan; 19(1):166-75. PubMed ID: 25609452
[TBL] [Abstract][Full Text] [Related]
10. Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-helicobacter pylori therapy.
Correa P; Fontham ET; Bravo JC; Bravo LE; Ruiz B; Zarama G; Realpe JL; Malcom GT; Li D; Johnson WD; Mera R
J Natl Cancer Inst; 2000 Dec; 92(23):1881-8. PubMed ID: 11106679
[TBL] [Abstract][Full Text] [Related]
11. Correlations among Helicobacter pylori infection and the expression of cyclooxygenase-2 and vascular endothelial growth factor in gastric mucosa with intestinal metaplasia or dysplasia.
Liu D; He Q; Liu C
J Gastroenterol Hepatol; 2010 Apr; 25(4):795-9. PubMed ID: 20492336
[TBL] [Abstract][Full Text] [Related]
12. Helicobacter pylori-related precancerous lesions in Turkey: a retrospective endoscopic surveillance study.
Bas B; Dinc B
Croat Med J; 2020 Aug; 61(4):319-325. PubMed ID: 32881429
[TBL] [Abstract][Full Text] [Related]
13. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial.
Wong BC; Lam SK; Wong WM; Chen JS; Zheng TT; Feng RE; Lai KC; Hu WH; Yuen ST; Leung SY; Fong DY; Ho J; Ching CK; Chen JS;
JAMA; 2004 Jan; 291(2):187-94. PubMed ID: 14722144
[TBL] [Abstract][Full Text] [Related]
14. Outcome of intestinal metaplasia in gastric biopsy of patients with dyspepsia in Guilan Province, North Iran.
Mansour-Ghanaei F; Joukar F; Soati F; Mansour-Ghanaei A; Atrkar-Roushan Z
Asian Pac J Cancer Prev; 2013; 14(6):3549-54. PubMed ID: 23886143
[TBL] [Abstract][Full Text] [Related]
15. Does treatment of Helicobacter pylori infection reduce gastric precancerous lesions?
Mansour-Ghanaei F; Joukar F; Mojtahedi K; Sokhanvar H; Askari K; Shafaeizadeh A
Asian Pac J Cancer Prev; 2015; 16(4):1571-4. PubMed ID: 25743833
[TBL] [Abstract][Full Text] [Related]
16. [Helicobacter pylori and the progression of gastric cancer: a 10-year cohort study].
Ma JL; Zhang L; Pan KF; Liu WD; Feng GS; You WC
Zhonghua Yi Xue Za Zhi; 2005 Oct; 85(39):2758-61. PubMed ID: 16324316
[TBL] [Abstract][Full Text] [Related]
17. Genetic polymorphisms in the cag pathogenicity island of Helicobacter pylori and risk of stomach cancer and high-grade premalignant gastric lesions.
Canzian F; Rizzato C; Obazee O; Stein A; Flores-Luna L; Camorlinga-Ponce M; Mendez-Tenorio A; Vivas J; Trujillo E; Jang H; Chen W; Kasamatsu E; Bravo MM; Torres J; Muñoz N; Kato I
Int J Cancer; 2020 Nov; 147(9):2437-2445. PubMed ID: 32363734
[TBL] [Abstract][Full Text] [Related]
18. Helicobacter pylori associated chronic gastritis, clinical syndromes, precancerous lesions, and pathogenesis of gastric cancer development.
Watari J; Chen N; Amenta PS; Fukui H; Oshima T; Tomita T; Miwa H; Lim KJ; Das KM
World J Gastroenterol; 2014 May; 20(18):5461-73. PubMed ID: 24833876
[TBL] [Abstract][Full Text] [Related]
19. Long-term effects and benefits of
Chen J; Zhang G; Qin J; Huang Y; Wang Y; Li Z; Ji D; Xiao L; Yin S; Bao Z
Saudi J Gastroenterol; 2022; 28(2):149-156. PubMed ID: 35083971
[TBL] [Abstract][Full Text] [Related]
20. Risk of gastric cancer in children with Helicobacter pylori infection.
Cam S
Asian Pac J Cancer Prev; 2014; 15(22):9905-8. PubMed ID: 25520126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]